Matches in Nanopublications for { <https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13252> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- 1753-0407.13252 type ScholarlyArticle assertion.
- 1753-0407.13252 type ScholarlyArticle assertion.
- 1753-0407.13252 type ScholarlyArticle assertion.
- 1753-0407.13252 description "Camaya I, Donnelly S, O'Brien B. Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. J Diabetes. 2022 Apr;14(4):247-260. doi: 10.1111/1753-0407.13252." assertion.
- 1753-0407.13252 description "Camaya I, Donnelly S, O'Brien B. Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. J Diabetes. 2022 Apr;14(4):247-260. doi: 10.1111/1753-0407.13252. " assertion.
- 1753-0407.13252 description "Camaya I, Donnelly S, O'Brien B. Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. J Diabetes. 2022 Apr;14(4):247-260. doi: 10.1111/1753-0407.13252. " assertion.
- 1753-0407.13252 identifier "https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13252" assertion.
- 1753-0407.13252 identifier "https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13252" assertion.
- 1753-0407.13252 identifier "https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13252" assertion.
- 1753-0407.13252 name "Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes" assertion.
- 1753-0407.13252 name "Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes" assertion.
- 1753-0407.13252 name "Targeting the PI3K/Akt signaling pathway in pancreatic β-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes" assertion.